Charles Schwab Investment Management Inc Wave Life Sciences Ltd. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 914,469 shares of WVE stock, worth $9.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
914,469
Previous 844,617 8.27%
Holding current value
$9.67 Million
Previous $6.93 Million 63.34%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$8.0 - $16.44 $558,816 - $1.15 Million
69,852 Added 8.27%
914,469 $11.3 Million
Q3 2024

Nov 12, 2024
BUY
$5.12 - $9.01 $2.93 Million - $5.15 Million
571,345 Added 209.08%
844,617 $6.93 Million
Q2 2024

Aug 12, 2024
SELL
$4.38 - $6.48 $702,135 - $1.04 Million
-160,305 Reduced 36.97%
273,272 $1.36 Million
Q1 2024

May 08, 2024
BUY
$3.54 - $6.84 $934,149 - $1.8 Million
263,884 Added 155.51%
433,577 $2.68 Million
Q3 2023

Nov 08, 2023
BUY
$3.56 - $5.75 $16,215 - $26,191
4,555 Added 2.76%
169,693 $975,000
Q2 2023

Aug 09, 2023
BUY
$3.51 - $4.69 $474,422 - $633,914
135,163 Added 450.92%
165,138 $601,000
Q4 2022

Feb 13, 2023
BUY
$3.18 - $7.0 $27,144 - $59,752
8,536 Added 39.82%
29,975 $209,000
Q3 2022

Nov 14, 2022
SELL
$2.37 - $4.28 $39,007 - $70,444
-16,459 Reduced 43.43%
21,439 $78,000
Q2 2022

Aug 15, 2022
SELL
$1.23 - $3.25 $72,876 - $192,559
-59,249 Reduced 60.99%
37,898 $124,000
Q1 2022

May 13, 2022
SELL
$2.0 - $3.28 $27,946 - $45,831
-13,973 Reduced 12.57%
97,147 $195,000
Q4 2021

Feb 11, 2022
BUY
$3.14 - $5.15 $55,329 - $90,748
17,621 Added 18.85%
111,120 $349,000
Q3 2021

Nov 16, 2021
SELL
$4.89 - $7.12 $759,426 - $1.11 Million
-155,302 Reduced 62.42%
93,499 $459,000
Q2 2021

Aug 16, 2021
BUY
$5.65 - $7.47 $112,011 - $148,092
19,825 Added 8.66%
248,801 $1.66 Million
Q1 2021

May 17, 2021
BUY
$5.61 - $12.01 $25,850 - $55,342
4,608 Added 2.05%
228,976 $1.29 Million
Q4 2020

Feb 16, 2021
BUY
$6.99 - $9.26 $546,939 - $724,557
78,246 Added 53.55%
224,368 $1.77 Million
Q3 2020

Nov 13, 2020
BUY
$8.49 - $19.54 $262,230 - $603,531
30,887 Added 26.8%
146,122 $1.24 Million
Q2 2020

Aug 14, 2020
SELL
$7.44 - $11.29 $46,321 - $70,291
-6,226 Reduced 5.13%
115,235 $1.2 Million
Q1 2020

May 15, 2020
BUY
$6.94 - $14.22 $20,931 - $42,887
3,016 Added 2.55%
121,461 $1.14 Million
Q4 2019

Feb 07, 2020
BUY
$7.99 - $37.6 $19,823 - $93,285
2,481 Added 2.14%
118,445 $950,000
Q3 2019

Nov 08, 2019
BUY
$19.17 - $27.4 $3,738 - $5,343
195 Added 0.17%
115,964 $2.38 Million
Q2 2019

Aug 09, 2019
BUY
$22.93 - $42.84 $212,629 - $397,255
9,273 Added 8.71%
115,769 $3.02 Million
Q1 2019

May 14, 2019
BUY
$32.69 - $47.91 $566,158 - $829,753
17,319 Added 19.42%
106,496 $4.14 Million
Q4 2018

Feb 14, 2019
SELL
$37.1 - $50.11 $47,079 - $63,589
-1,269 Reduced 1.4%
89,177 $3.75 Million
Q3 2018

Nov 13, 2018
BUY
$36.35 - $55.2 $254,559 - $386,565
7,003 Added 8.39%
90,446 $4.52 Million
Q2 2018

Aug 08, 2018
BUY
$33.85 - $50.65 $494,717 - $740,249
14,615 Added 21.23%
83,443 $3.19 Million
Q1 2018

May 07, 2018
SELL
$32.45 - $54.7 $181,492 - $305,937
-5,593 Reduced 7.52%
68,828 $2.76 Million
Q4 2017

Jan 17, 2018
BUY
$21.8 - $39.35 $389,871 - $703,735
17,884 Added 31.63%
74,421 $2.61 Million
Q3 2017

Nov 13, 2017
BUY
$16.4 - $25.05 $927,206 - $1.42 Million
56,537
56,537 $1.23 Million

Others Institutions Holding WVE

# of Institutions
192
Shares Held
122M
Call Options Held
430K
Put Options Held
330K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $918M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email